Abstract
The replication of human immunodeficiency virus in vitro is inhibited by some acyclic adenosine derivatives, such as 9-(2-phosphonylmethoxyethyl)adenine (PMEA) and (S)-9-(3-hydroxy-2-phosphonylmethoxypropyl)-2,6-diaminopurine [(S)-HPMPDAP], as well as by 3'-azido-3'-deoxythymidine (AZT). In a human T-lymphocyte cell line, C3, at 6 days postinfection, the 50% effective concentration (EC50) of AZT was 0.02 microM and the 90% effective concentration (EC90) was 0.33 microM; for PMEA, the EC50 was 1.9 microM and the EC90 was 27 microM. For (S)-HPMPDAP, the EC50 was 2.3 microM and the EC90 was 36 microM. Most combinations of AZT and PMEA produced a synergistic effect. In the T-cell line C3, the combination indices for 50 to 90% inhibition of virus replication ranged from 0.25 to 1.25. Combinations of PMEA (or other members of this group) with AZT appear to be worth further study for the possible treatment of acquired immunodeficiency syndrome.
References
Jun 29, 1985·Lancet·E G SandstromM S Hirsch
Oct 1, 1985·Proceedings of the National Academy of Sciences of the United States of America·H MitsuyaS Broder
Dec 1, 1986·Antimicrobial Agents and Chemotherapy·H NakashimaN Yamamoto
Mar 13, 1987·Science·M W VogtM S Hirsch
Jul 1, 1987·Antiviral Research·M ItoS Shigeta
Dec 1, 1987·Journal of Virology·M S SmithJ S Pagano
Oct 1, 1987·Antimicrobial Agents and Chemotherapy·H NakashimaN Yamamoto
Sep 1, 1987·Antimicrobial Agents and Chemotherapy·J C LinJ S Pagano
Dec 1, 1987·Proceedings of the National Academy of Sciences of the United States of America·M G DavisE S Huang
Jan 7, 1988·Nature·R A FisherR T Schooley
Mar 1, 1988·Proceedings of the National Academy of Sciences of the United States of America·S KenneyJ Pagano
Mar 11, 1988·Science·G J NabelD Baltimore
Jul 1, 1988·Antimicrobial Agents and Chemotherapy·R PauwelsE De Clercq
Mar 16, 1985·Lancet·D D HoM S Hirsch
Oct 31, 1987·Lancet·A S TymsD J Jeffries
Nov 5, 1987·Nature·R A GrutersH L Ploegh
Mar 1, 1986·Proceedings of the National Academy of Sciences of the United States of America·H Mitsuya, S Broder
Jun 1, 1986·Proceedings of the National Academy of Sciences of the United States of America·P C ZamecnikP S Sarin
Jan 1, 1987·Nature·J D MoscaP M Pitha
May 1, 1987·Proceedings of the National Academy of Sciences of the United States of America·D C Montefiori, W M Mitchell
Jul 23, 1987·The New England Journal of Medicine·M A FischlR T Schooley
Jul 23, 1987·The New England Journal of Medicine·D D RichmanM S Hirsch
Dec 1, 1987·Antiviral Research·E De ClercqA Holý
Mar 1, 1987·Antiviral Research·M ItoN Yamamoto
Nov 1, 1987·Proceedings of the National Academy of Sciences of the United States of America·M MatsukuraS Broder
Oct 2, 1986·Nature·E De ClercqP C Maudgal
Oct 12, 1984·Science·H MitsuyaS Broder
Dec 15, 1984·Lancet·J B McCormickD R Hicks
Jan 1, 1984·Advances in Enzyme Regulation·T C Chou, P Talalay
Citations
Aug 1, 1991·Journal of Virological Methods·N K AyisiL F Qualtiere
May 1, 1991·Antiviral Research·M ItoT Miyasaka
Oct 1, 1996·Antiviral Research·A FoliR Yarchoan
Aug 1, 1996·Trends in Microbiology·D E Hassett, J L Whitton
Jun 22, 2002·Antiviral Research·Mohammad M HossainDavid M Margolis
Nov 14, 1997·General Pharmacology·M Witvrouw, E De Clercq
Mar 3, 1998·Trends in Microbiology·A M KriegH L Davis
Jul 9, 1999·AIDS·S PalmerT C Merigan
Feb 1, 1994·Journal of Medical Primatology·C C TsaiR Benveniste
Jan 1, 1991·Antimicrobial Agents and Chemotherapy·M S SmithJ S Pagano
Nov 1, 1991·Antimicrobial Agents and Chemotherapy·J C LinJ S Pagano
Jul 1, 1991·Antimicrobial Agents and Chemotherapy·M BabaE De Clercq
Mar 18, 2000·Antimicrobial Agents and Chemotherapy·W T HughesJ S Read
Nov 26, 2013·Pharmaceutical Research·Denisa DiblíkováKateřina Vávrová
Nov 26, 2005·Uirusu·Wataru Sugiura
Nov 18, 2000·Virology·M S SmithO Narayan
Sep 14, 1990·Biochemical and Biophysical Research Communications·I C BathurstP J Barr
Jun 1, 1992·AIDS Research and Human Retroviruses·R F SchinaziP M Feorino
Apr 22, 2009·AIDS·Brij B SaxenaSidney Lerner
Aug 3, 1999·Antimicrobial Agents and Chemotherapy·S PalmerT C Merigan
Jun 6, 2000·Advanced Drug Delivery Reviews·X TanF D Boudinot
Apr 1, 1995·Clinical Microbiology Reviews·E De Clercq